Chatterjee Receives NSF CAREER Award To Advance the Future of Medical Electronics Through Body-Coupled Network of Devices
Baibhab Chatterjee, Ph.D. has received a prestigious National Science Foundation (NSF) CAREER Award, the agency’s highest honor for early-career faculty.
Prestigious NIH Training Grant To Support Doctoral Education in Biomedical Science
The National Institute of General Medical Sciences (NIGMS), a branch of the National Institutes of Health, has awarded UF a competitive T32 Institutional Research Training Grant to support doctoral training in biomedical research.
UF Genetics Institute Awarded Prestigious NIH Training Grant To Support Doctoral Education in Biomedical Science
The UF Genetics Institute has been awarded a $2.98 million grant by the National Institute of General Medical Sciences (NIGMS) to support doctoral education in genetics, genomics, and molecular pharmacology.
University of Florida Sets New Records in Technology Transfer Metrics for Fiscal Year 2025
UF has demonstrated its leadership in innovation and technology transfer by setting new records in key metrics for fiscal year 2025, with significant increases in technology disclosures, executed licenses, patent applications, and material transfer agreements.
Scientist’s Cat, Again, Helps Discover New Virus
A UF researcher’s cat caught a shrew carrying a previously unidentified strain of orthoreovirus—an unexpected find that helped researchers better understand the transmission of mule deerpox virus.
UF/IFAS Scientist Uses AI To Target Weeds — Not Nearby Tomatoes – Saving 70% of Herbicide
UF research shows that targeted weed-spraying can help tomato farmers reduce herbicide use by 71%, significantly lowering the amount released into the environment.
Atsena Therapeutics Announces Alignment With FDA on Regulatory Pathway to Approval for ATSN-201 in X-Linked Retinoschisis (XLRS)
UF startup Atsena Therapeutics received FDA approval to expand its Phase 1/2 LIGHTHOUSE study of ATSN-201 into a pivotal Phase 1/2/3 trial to support a BLA submission for treating X-linked retinoschisis (XLRS).
Antibody-Cancer Drug Combo Shows Promise Against Aggressive Lymphoma
A study from UF researchers shows that cancer-targeting antibodies combined with a natural compound from soil microbes form a powerful treatment against an aggressive type of blood cancer.
UF and Other Research Universities Will Fuel AI. Here’s Why
Alina Zare Ph.D., director of UF Artificial Intelligence and Informatics Research Institute, highlights how UF is helping shape the future of AI—positioning research universities as drivers of the next wave of innovation.
Forecasting the Final Frontier: How Research Prepares U.S. for the Next Solar Storm
UF researchers are developing solutions to help shield the U.S. from the next major solar storm by forecasting and modeling solar energetic particles and their impact on spacecraft and space-based infrastructure.